1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA PADI4 CTRPv2 pan-cancer AAC 0.09 0.009
mRNA CDS1 CTRPv2 pan-cancer AAC 0.11 0.009
mRNA KCTD19 CTRPv2 pan-cancer AAC -0.091 0.009
mRNA GMFG CTRPv2 pan-cancer AAC 0.13 0.009
mRNA DNA2 CTRPv2 pan-cancer AAC -0.098 0.009
mRNA CHST11 CTRPv2 pan-cancer AAC 0.1 0.009
mRNA TNPO1 CTRPv2 pan-cancer AAC -0.097 0.009
mRNA GPR143 CTRPv2 pan-cancer AAC 0.097 0.009
mRNA RRAS CTRPv2 pan-cancer AAC -0.1 0.009
mRNA AMT CTRPv2 pan-cancer AAC 0.094 0.009
Download CSV